• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌中凋亡相关分子表达谱的改变与临床病理因素相关

Altered expression profile of apoptosis-related molecules correlated with clinicopathological factors in non-small-cell lung cancer.

作者信息

Huang Jian-Qing, Liang Hong-Ling, Jin Tian-En, Xie Zhi

机构信息

Cancer Center of Guangzhou Medical University Guangzhou 510095, China.

Guangdong Lung Cancer Institute, Guangdong General Hospital Guangzhou 510080, China.

出版信息

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11278-86. eCollection 2015.

PMID:26647102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4637667/
Abstract

Apoptosis-related molecules can be abnormally expressed in cancers and underscore the hallmark of resisting cell death in cancer cells. This study was aimed to observe the expression patterns of apoptosis-related molecules in lung cancer and paired non-cancerous tissues, and to observe if there is a correlation between the expression of these apoptotic molecules and clinicopathologic parameters. Immunohistochemistry (IHC) was performed to analyze the expression level of CASP3, CASP8, CASP9, PARP1, Cleaved CASP3 (C-CASP3), Cleaved PARP1 (C-PARP1), XIAP, BIRC5 (Survivin) and BCL2 in lung cancer and paired non-cancerous tissues. We found that apoptosis-related molecules CASP3, CASP9, BCL2, BIRC5 and PARP1 are abnormally expressed in lung cancer cells and their expression were correlated with histology. BCL2, BIRC5 and PARP1 are expressed at higher levels in SCC than in non-SCC. C-PARP1 expression might be an independent prognostic factor for NSCLC.

摘要

凋亡相关分子在癌症中可异常表达,并突显了癌细胞抵抗细胞死亡的特征。本研究旨在观察凋亡相关分子在肺癌及配对的癌旁组织中的表达模式,并观察这些凋亡分子的表达与临床病理参数之间是否存在相关性。采用免疫组织化学(IHC)方法分析肺癌及配对癌旁组织中CASP3、CASP8、CASP9、PARP1、裂解的CASP3(C-CASP3)、裂解的PARP1(C-PARP1)、XIAP、BIRC5(存活素)和BCL2的表达水平。我们发现凋亡相关分子CASP3、CASP9、BCL2、BIRC5和PARP1在肺癌细胞中异常表达,且它们的表达与组织学相关。BCL2、BIRC5和PARP1在鳞状细胞癌(SCC)中的表达水平高于非SCC。C-PARP1的表达可能是非小细胞肺癌(NSCLC)的一个独立预后因素。

相似文献

1
Altered expression profile of apoptosis-related molecules correlated with clinicopathological factors in non-small-cell lung cancer.非小细胞肺癌中凋亡相关分子表达谱的改变与临床病理因素相关
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11278-86. eCollection 2015.
2
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.NQO1基因多态性及p53、SOD2、PARP1在局限期小细胞肺癌中的表达的临床意义
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6743-51. eCollection 2014.
3
Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.非小细胞肺癌中Gankyrin蛋白表达的临床病理特征及预后意义
Pathol Res Pract. 2015 Dec;211(12):939-47. doi: 10.1016/j.prp.2015.09.010. Epub 2015 Sep 10.
4
Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.人非小细胞肺癌中Fas、FasL、p53和bcl-2表达的关系
Int J Clin Exp Pathol. 2015 Nov 1;8(11):13978-86. eCollection 2015.
5
A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population.中国人群非小细胞肺癌中凋亡相关蛋白表达的多标志物分析
Folia Histochem Cytobiol. 2011;49(2):231-9. doi: 10.5603/fhc.2011.0032.
6
Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.整合素α6β4表达升高与非小细胞肺癌的静脉侵犯及总生存期缩短相关。
Hum Pathol. 2016 Aug;54:174-83. doi: 10.1016/j.humpath.2016.04.003. Epub 2016 Apr 20.
7
Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.BCL2的过表达可阻断肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的人肺癌细胞凋亡。
Biochem Biophys Res Commun. 2001 Jan 26;280(3):788-97. doi: 10.1006/bbrc.2000.4218.
8
Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer.基质金属蛋白酶-2、小鼠双微体2同源物及表皮生长因子受体过表达在非小细胞肺癌中的预后意义
J BUON. 2016 Mar-Apr;21(2):341-8.
9
Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.ETV6/TEL的表达与非小细胞肺癌的预后相关。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2937-45. eCollection 2015.
10
Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.赖氨酰氧化酶与MMP2/MMP9表达的相关性及其在非小细胞肺癌中的预后价值
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6040-7. eCollection 2014.

引用本文的文献

1
MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA.微小 RNA-326 通过抑制组蛋白去乙酰化酶 SIRT1 介导的 HIF1α 和上调 VEGFA 来损害非小细胞肺癌的化疗耐药性。
Bioengineered. 2022 Mar;13(3):5685-5699. doi: 10.1080/21655979.2021.1993718.
2
Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps.Bcl-2 介导的非小细胞肺癌细胞系 NCI-H460 中 TRAIL 诱导的凋亡反应的控制作用在晚期半胱氨酸蛋白酶加工步骤中是有效的。
PLoS One. 2018 Jun 21;13(6):e0198203. doi: 10.1371/journal.pone.0198203. eCollection 2018.

本文引用的文献

1
mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy.mTOR抑制剂通过诱导自噬使携带EGFR激活突变的PTEN缺陷型非小细胞肺癌细胞对放疗敏感。
J Cell Biochem. 2013 Jun;114(6):1248-56. doi: 10.1002/jcb.24465.
2
PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.聚腺苷二磷酸核糖聚合酶抑制剂选择性地增加 ERCC1 低表达非小细胞肺癌细胞对顺铂的敏感性。
Carcinogenesis. 2013 Apr;34(4):739-49. doi: 10.1093/carcin/bgs393. Epub 2012 Dec 28.
3
Development and strategies of VEGFR-2/KDR inhibitors.VEGFR-2/KDR 抑制剂的研发与策略。
Future Med Chem. 2012 Sep;4(14):1839-52. doi: 10.4155/fmc.12.121.
4
PARP inhibition in epithelial ovarian cancer: high hopes undergo a reality check.聚腺苷二磷酸核糖聚合酶抑制剂在卵巢上皮性癌中的应用:希望与现实的碰撞。
Oncology (Williston Park). 2012 Feb;26(2):128-36.
5
ROS1 rearrangements define a unique molecular class of lung cancers.ROS1 重排定义了一类独特的肺癌分子亚型。
J Clin Oncol. 2012 Mar 10;30(8):863-70. doi: 10.1200/JCO.2011.35.6345. Epub 2012 Jan 3.
6
Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737.Pim 激酶抑制剂使前列腺癌细胞对 Bcl-2 家族抑制剂 ABT-737 触发的细胞凋亡敏感。
Cancer Res. 2012 Jan 1;72(1):294-303. doi: 10.1158/0008-5472.CAN-11-3240. Epub 2011 Nov 11.
7
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
8
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
9
Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease? Evaluation of Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363(18):1693-703.克唑替尼治疗间变性淋巴瘤激酶阳性肺腺癌:晚期疾病的希望?评价 Kwak EL、Bang YJ、Camidge DR 等人的研究。间变性淋巴瘤激酶抑制在非小细胞肺癌中的作用。《新英格兰医学杂志》2010;363(18):1693-703。
Expert Opin Ther Targets. 2011 Mar;15(3):351-3. doi: 10.1517/14728222.2011.550880. Epub 2011 Jan 5.
10
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis.ABT-263,一种 Bcl-2 抑制剂,增强了Src 抑制剂处理的肺腺癌细胞对失巢凋亡的敏感性。
Oncol Rep. 2011 Mar;25(3):661-7. doi: 10.3892/or.2010.1123. Epub 2010 Dec 27.